CD8A and neoplasm: To assess MHC class I antigen-dependent tumor cell recognition, CD8+ T cells stimulated with DC pulsed with EpiTCer beads, ETV6 or NUP210 9mer peptides separately or pooled, were re-stimulated with ANRU tumor cells with and without MHC class I blocking antibody (W6/32).